In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants.
about
Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumabProgress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsVaccine-induced pathogen strain replacement: what are the mechanisms?Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein.Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected childrenInitiating a watch list for Ebola virus antibody escape mutations.Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.Neutralizing epitopes of RSV and palivizumab resistance in Japan.Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virusThe role of virulence in in vivo superinfection fitness of the vertebrate RNA virus infectious hematopoietic necrosis virus.Selection and characterization of human respiratory syncytial virus escape mutants resistant to a polyclonal antiserum raised against the F protein.
P2860
Q33591243-EADFBA36-709F-476E-92EF-08BEBF422201Q34772752-5E8DF9ED-C522-443A-9841-C93ED39AF7A1Q35566601-52A58016-50F7-42C1-813E-C2B8B9A22D74Q36801980-8E7C237C-5744-44ED-A3D9-538A3DF5C826Q37071608-CDD764BB-BC85-4619-B16C-86BF5BDEA8FDQ37732535-EC95310C-3304-4E6A-909F-6641D1E755F0Q38305707-9CBEF6FE-D3C6-4504-9683-950001BF5C01Q38647393-37798D1D-EEA7-4487-B009-F8A91D71D2E0Q38750689-CD60DC30-15F3-4B9C-8851-E97AF5831060Q40059727-5D465F15-38B5-4A08-B0FA-3E0D21A39533Q41816990-AE80F057-1462-48E0-A568-5D1A8EF0B129Q41973717-C5429F19-BD05-4835-BF84-52E6F3AADCBEQ45359023-0017B0B8-F14D-43AC-90FE-8D53F6C9BF61
P2860
In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
In vitro and in vivo fitness o ...... lonal antibody escape mutants.
@ast
In vitro and in vivo fitness o ...... lonal antibody escape mutants.
@en
type
label
In vitro and in vivo fitness o ...... lonal antibody escape mutants.
@ast
In vitro and in vivo fitness o ...... lonal antibody escape mutants.
@en
prefLabel
In vitro and in vivo fitness o ...... lonal antibody escape mutants.
@ast
In vitro and in vivo fitness o ...... lonal antibody escape mutants.
@en
P2093
P2860
P356
P1433
P1476
In vitro and in vivo fitness o ...... lonal antibody escape mutants.
@en
P2093
Fu-Ping Chen
Wayne M Sullender
Xiaodong Zhao
P2860
P304
11651-11657
P356
10.1128/JVI.01387-06
P407
P577
2006-09-27T00:00:00Z